A Multiple-dose Study of LY3031207 in Healthy Participants

This study has been terminated.
(Elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in some participants.)
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT01632566
First received: June 25, 2012
Last updated: April 30, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)